- Tytuł:
- A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation
- Autorzy:
- Źródło:
- In Transplantation and Cellular Therapy February 2023
Czasopismo naukowe